Studies
Study | Inclusion criteria | Study goal | Contact | Information |
---|---|---|---|---|
Freder1k study
|
| Free early detection of an increased type 1 diabetes risk immediately after birth as part of the newborn screening or during a subsequent visit to the pediatrician up to the age of 4 months. The type 1 diabetes risk genes are determined based on a few drops of blood. If there is an increased risk of type 1 diabetes, participation in type 1 diabetes prevention studies is offered (including the POInT study, see below). | Dr. Christiane Winkler tel.: 0800-000 00 18 |
|
POInT trial
|
| The POInT (Primary Oral Insulin Trial) trial aims to prevent the development of islet autoimmunity and the development of type 1 diabetes. The daily intake of insulin powder with food intends to train and sensitize the immune system at an early stage so that defective autoimmunity does not occur. | Univ.-Prof. Dr. med. Anette-Gabriele Ziegler PD Dr. med. Peter Achenbach tel.: 0800-000 00 18 (free) |
|
Fr1daplus study
|
| The Fr1daplus study "Type 1 diabetes: early detection - early treatment" detects an early stage of type 1 diabetes. Early diagnosis means that it is possible to treat type 1 diabetes from the outset and to avoid metabolic disorders. It is possible to participate in the prevention study Fr1da Insulin Intervention. The study aims to delay or stop the progression of the disease (see below). | Univ.-Prof. Dr. med. Anette-Gabriele Ziegler tel.: 0800–4648835 (free) |
Website (German) |
Fr1da Insulin Intervention trial
|
| Study participants - children with an early stage of type 1 diabetes - receive oral insulin powder to prevent the development of type 1 diabetes by immune sensitization. The insulin does not lower blood sugar levels, but is intended to have a positive effect on the immune system, similar to a protective vaccination. | Univ.-Prof. Dr. med. Anette-Gabriele Ziegler tel.: 0800–4648835 (free) |
Website (German) |
Early detection of type 1 diabetes for relatives
|
| Close relatives of people with type 1 diabetes have an increased risk of developing type 1 diabetes. For this reason, we offer them a free test to detect an early stage of the disease. Participation is possible in all of Germany. | Univ.-Prof. Dr. med. Anette-Gabriele Ziegler tel.: 0800–4648835 (free) |
Website (German) |